查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566887

羊膜产品市场：按产品、应用和最终用户分类：2024-2033 年全球机会分析和产业预测

Amniotic Product Market By Product , By Application By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

羊膜产品市场

2023年羊膜产品市值为9亿美元，预计2024年至2033年复合年增长率为6.9%，到2033年将达18亿美元。

羊膜产品，包括羊膜和胎盘液，由于含有细胞激素、生长因子和细胞外基质成分，是再生医学的重要组成部分。羊膜产品可用于促进组织修復、减少发炎和预防疤痕，并以移植物、贴片、注射和局部溶液的形式提供。羊膜产品的作用涉及输送生物活性分子，促进细胞迁移、增殖和分化，从而促进癒合和减少发炎。

组织工程的进步促进了维持羊膜产品生物活性的创新技术的发展。这些技术创新是羊膜产品市场的关键驱动因素。此外，人们对干细胞治疗和再生医学的日益偏好正在推动促进组织再生和修復的羊膜产品的采用。静电纺丝和增材製造技术的使用正在推动羊膜产品在组织工程中的使用扩大。这些技术有助于开发新型多层复合羊膜，可用于神经再生等多种临床应用。

羊水属于 FDA 公共卫生服务法第 351 条的管辖范围。然而，由于遵守政府机构和美国食品和药物协会（FDA）等联邦机构实施的法规的途径昂贵且耗时，羊水产品市场发展状况非常具有挑战性。因此，羊水产品的使用和销售需要获得核准的生技药品许可证申请。如果没有执照，您将受到严厉的处罚和处罚。

分部审查

羊膜产品市场分为产品、应用、最终用户和地区。从产品角度来看，市场分为冷冻羊膜和冷冻干燥羊膜。依用途分为外科伤口、眼科、整形外科等。依最终使用者分为医院、门诊手术中心、专科诊所、研究中心和实验室。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

副产品中，冷冻羊膜占有较高的市场占有率。

从应用来看，外科伤口领域占有很大份额。

从最终用户来看，医院部门占有很高的份额。

按地区划分，北美在羊膜产品市场中收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 历史市场资料
  • 导入/汇出分析/资料
  • 赎回场景

目录

第一章 简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章 人造丝产品市场：副产品

  • 市场概况
  • 冷冻保存羊膜
  • 冻干羊膜

第五章羊水产品市场：依应用分类

  • 市场概况
  • 手术伤口
  • 眼科
  • 整形外科
  • 其他的

第六章 Amiotech 产品市场：依最终用户划分

  • 市场概况
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 研究中心研究所

第七章羊膜产品市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国羊膜产品市场
    • 加拿大羊膜产品市场
    • 墨西哥羊膜产品市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国羊膜产品市场
    • 德国羊膜产品市场
    • 义大利羊膜产品市场
    • 西班牙羊膜产品市场
    • 英国羊膜产品市场
    • 其他欧洲国家羊膜产品市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国羊膜製品市场
    • 日本羊膜产品市场
    • 印度羊膜产品市场
    • 韩国羊膜产品市场
    • 澳洲羊膜产品市场
    • 其他亚太羊水产品市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西羊膜产品市场
    • 南非羊膜产品市场
    • 沙乌地阿拉伯羊膜产品市场
    • 其他拉丁美洲/中东/非洲羊膜产品市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Allosure, Inc.
  • Amnio Technology, LLC
  • Applied Biologics LLC
  • FzioMed, Inc.
  • Human Regenerative Technologies, LLC
  • Integra Lifesciences Holdings Corporation
  • Corza Ophthalmology
  • MiMedx Group, Inc.
  • Skye Biologics Inc.
  • Tissue-Tech, Inc.
简介目录
Product Code: A216556

Amniotic Product Market

The amniotic product market was valued at $0.9 billion in 2023 and is projected to reach $1.8 billion by 2033, growing at a CAGR of 6.9% from 2024 to 2033.

Amniotic product, including amniotic membrane and fluid of the placenta, is an essential component of regenerative medicine due to the presence of cytokines, growth factors, and extracellular matrix components. The products are useful in the promotion of tissue repair, reduction of inflammation, & scar prevention and are available in the form of grafts, patches, injections, and topical solutions. The working of amniotic products includes the delivery of bioactive molecules to enhance cellular migration, proliferation, and differentiation, which results in accelerated healing & reduced inflammation.

Advancements in tissue engineering have led to the development of innovative techniques for preserving the bioactivity of amniotic products. These innovations are a key driver of the amniotic product market. In addition, surge in preference for stem cell therapies and regenerative medicine is boosting the adoption of amniotic products, as they promote tissue regeneration and repair. To expand the usage of amniotic products in tissue engineering, the usage of electrospinning and additive manufacturing technologies is acquiring traction. These technologies help in the development of novel multilayer composite-based amniotic membranes which are utilized for several clinical applications such as nerve regeneration.

However, the development landscape for the amniotic product market is highly challenging due to the expensive and time-consuming pathway regarding compliance with the regulations imposed by the government or federal agencies such as the Food and Drug Association (FDA) in the U.S. Amniotic fluid falls under Section 351 of the Public Health Service Act by the FDA. Hence, usage and marketing of the amniotic products require an approved Biologics License Application. The case of non-availability of the license leads to heavy penalties and punishment.

Segment Review

The amniotic product market is segmented into product, application, end user, and region. On the basis of product, the market is bifurcated into cryopreserved amniotic and lyophilization amniotic. As per application, it is classified into surgical wounds, ophthalmology, orthopedic, and others. By end user, it is divided into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the cryopreserved amniotic segment accounts for a high market share.

As per application, the surgical wounds segment acquires a high stake in the market.

By end user, the hospitals segment holds a high share in the market.

Region wise, North America generates the highest revenue in the amniotic product market.

Competition Analysis

The leading players operating in the global amniotic product market include Allosure, Inc., Amnio Technology, LLC, applied biologics llc, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc., Skye Biologics Inc., and Tissue-Tech, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Historic market data
  • Import Export Analysis/Data
  • Reimbursement Scenario

Key Market Segments

By Product

  • Cryopreserved Amniotic
  • Lyophilization Amniotic

By Application

  • Surgical Wounds
  • Ophthalmology
  • Orthopedic
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers Laboratory

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Allosure, Inc.
    • Amnio Technology, LLC
    • applied biologics llc
    • FzioMed, Inc.
    • Human Regenerative Technologies, LLC
    • Integra Lifesciences Holdings Corporation
    • Corza Ophthalmology
    • MiMedx Group, Inc.
    • Skye Biologics Inc.
    • Tissue-Tech, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: AMNIOTIC PRODUCT MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Cryopreserved Amniotic
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Lyophilization Amniotic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: AMNIOTIC PRODUCT MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Surgical Wounds
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ophthalmology
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Orthopedic
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: AMNIOTIC PRODUCT MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Specialized Clinics
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Research Centers Laboratory
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AMNIOTIC PRODUCT MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Amniotic Product Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Amniotic Product Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Amniotic Product Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Amniotic Product Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Amniotic Product Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Amniotic Product Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Amniotic Product Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Amniotic Product Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Amniotic Product Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Amniotic Product Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Amniotic Product Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Amniotic Product Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Amniotic Product Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Amniotic Product Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Amniotic Product Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Amniotic Product Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Amniotic Product Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Amniotic Product Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Amniotic Product Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Allosure, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Amnio Technology, LLC
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Applied Biologics LLC
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. FzioMed, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Human Regenerative Technologies, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Integra Lifesciences Holdings Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Corza Ophthalmology
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MiMedx Group, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Skye Biologics Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Tissue-Tech, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments